AAAAAA
Results:
1-10
|
Results: 10
Authors:
Cwynarski, K
Goulding, R
Pocock, C
Dazzi, F
Craddock, C
Kaeda, J
Olavarria, E
Kanfer, E
Apperley, J
Lawler, M
Goldman, JM
Citation: K. Cwynarski et al., Immune haemolytic anaemia following T cell-depleted allogeneic bone marrowtransplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusions, BONE MAR TR, 28(6), 2001, pp. 581-586
Authors:
Amrolia, PJ
Vulliamy, T
Vassiliou, G
Lawson, S
Bryon, J
Kaeda, J
Dokal, I
Johnston, R
Veys, P
Darbyshire, P
Roberts, IAG
Citation: Pj. Amrolia et al., Analysis of chimaerism in thalassaemic children undergoing stem cell transplantation, BR J HAEM, 114(1), 2001, pp. 219-225
Authors:
Olavarria, E
Kanfer, E
Szydlo, R
Kaeda, J
Rezvani, K
Cwynarski, K
Pocock, C
Dazzi, F
Craddock, C
Apperley, JF
Cross, NCP
Goldman, JM
Citation: E. Olavarria et al., Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia, BLOOD, 97(6), 2001, pp. 1560-1565
Authors:
Kulkarni, S
Heath, C
Parker, S
Chase, A
Iqbal, S
Pocock, CF
Kaeda, J
Cwynarski, K
Goldman, JM
Cross, NCP
Citation: S. Kulkarni et al., Fusion of H4/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21), CANCER RES, 60(13), 2000, pp. 3592-3598
Authors:
Dazzi, F
Szydlo, RM
Cross, NCP
Craddock, C
Kaeda, J
Kanfer, E
Cwynarski, K
Olavarria, E
Yong, A
Apperley, JF
Goldman, JM
Citation: F. Dazzi et al., Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia, BLOOD, 96(8), 2000, pp. 2612-2616
Authors:
Dazzi, F
Szydlo, RM
Cross, NCP
Craddock, C
Kaeda, J
Kanfer, E
Cwynarski, K
Olavarria, E
Yong, A
Apperley, JF
Goldman, JM
Citation: F. Dazzi et al., Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia, BLOOD, 96(8), 2000, pp. 2712-2716
Authors:
Chase, A
Parker, S
Kaeda, J
Sivalingam, R
Cross, NCP
Goldman, JM
Citation: A. Chase et al., Absence of host-derived cells in the blood of patients in remission after allografting for chronic myeloid leukemia, BLOOD, 96(2), 2000, pp. 777-778
Authors:
Hochhaus, A
Reiter, A
Saussele, S
Reichert, A
Emig, M
Kaeda, J
Schultheis, B
Berger, U
Shepherd, PCA
Allan, NC
Hehlmann, R
Goldman, JM
Cross, NCP
Citation: A. Hochhaus et al., Molecular heterogeneity in complete cytogenetic responders after interferon-alpha therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission, BLOOD, 95(1), 2000, pp. 62-66
Authors:
Dazzi, F
Szydlo, RM
Craddock, C
Cross, NCP
Kaeda, J
Chase, A
Olavarria, E
van Rhee, F
Kanfer, E
Apperley, JF
Goldman, JM
Citation: F. Dazzi et al., Comparison of single-dose and escalating-dose regimens of donor lymphocyteinfusion for relapse after allografting for chronic myeloid leukemia, BLOOD, 95(1), 2000, pp. 67-71
Authors:
Sonati, MD
Kaeda, J
Kimura, EM
Costa, FF
Luzzatto, L
Citation: Md. Sonati et al., Mild clinical expression of S-beta thalassemia in a Brazilian patient withthe beta(+) IVS-I-6 (T -> C) mutation, GENET MOL B, 21(4), 1998, pp. 431-433
Risultati:
1-10
|